ImmunityBio will lay off 16 employees in El Segundo, California, and said it expects to need more funding to commercialize Anktiva, approved in April for non-muscle invasive bladder cancer.
ImmunityBio will lay off 16 employees in El Segundo, California, and said it expects to need more funding to commercialize Anktiva, approved in April for non-muscle invasive bladder cancer.